Fulgent Genetics (FLGT) Competitors $17.05 +0.20 (+1.19%) Closing price 03/28/2025 04:00 PM EasternExtended Trading$17.02 -0.04 (-0.21%) As of 03/28/2025 06:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock FLGT vs. ARDT, PGNY, AGL, PACS, ADUS, TDOC, NHC, AHCO, VRDN, and GRALShould you be buying Fulgent Genetics stock or one of its competitors? The main competitors of Fulgent Genetics include Ardent Health Partners (ARDT), Progyny (PGNY), agilon health (AGL), PACS Group (PACS), Addus HomeCare (ADUS), Teladoc Health (TDOC), National HealthCare (NHC), AdaptHealth (AHCO), Viridian Therapeutics (VRDN), and Grail (GRAL). These companies are all part of the "healthcare" industry. Fulgent Genetics vs. Ardent Health Partners Progyny agilon health PACS Group Addus HomeCare Teladoc Health National HealthCare AdaptHealth Viridian Therapeutics Grail Fulgent Genetics (NASDAQ:FLGT) and Ardent Health Partners (NYSE:ARDT) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, institutional ownership, community ranking, dividends, risk, earnings, media sentiment and valuation. Is FLGT or ARDT more profitable? Ardent Health Partners has a net margin of 0.00% compared to Fulgent Genetics' net margin of -59.39%. Ardent Health Partners' return on equity of 0.00% beat Fulgent Genetics' return on equity.Company Net Margins Return on Equity Return on Assets Fulgent Genetics-59.39% -1.81% -1.66% Ardent Health Partners N/A N/A N/A Does the media refer more to FLGT or ARDT? In the previous week, Ardent Health Partners had 5 more articles in the media than Fulgent Genetics. MarketBeat recorded 11 mentions for Ardent Health Partners and 6 mentions for Fulgent Genetics. Fulgent Genetics' average media sentiment score of 1.30 beat Ardent Health Partners' score of 1.03 indicating that Fulgent Genetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fulgent Genetics 4 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Ardent Health Partners 6 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Which has stronger valuation & earnings, FLGT or ARDT? Ardent Health Partners has higher revenue and earnings than Fulgent Genetics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioFulgent Genetics$283.47M1.86-$167.82M-$1.41-12.09Ardent Health Partners$5.97B0.32$53.90MN/AN/A Does the MarketBeat Community favor FLGT or ARDT? Fulgent Genetics received 224 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 86.96% of users gave Ardent Health Partners an outperform vote while only 59.80% of users gave Fulgent Genetics an outperform vote. CompanyUnderperformOutperformFulgent GeneticsOutperform Votes24459.80% Underperform Votes16440.20% Ardent Health PartnersOutperform Votes2086.96% Underperform Votes313.04% Do institutionals & insiders have more ownership in FLGT or ARDT? 48.1% of Fulgent Genetics shares are held by institutional investors. 31.8% of Fulgent Genetics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts rate FLGT or ARDT? Fulgent Genetics presently has a consensus price target of $16.00, indicating a potential downside of 6.16%. Ardent Health Partners has a consensus price target of $21.18, indicating a potential upside of 60.77%. Given Ardent Health Partners' stronger consensus rating and higher possible upside, analysts plainly believe Ardent Health Partners is more favorable than Fulgent Genetics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Fulgent Genetics 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Ardent Health Partners 0 Sell rating(s) 2 Hold rating(s) 8 Buy rating(s) 2 Strong Buy rating(s) 3.00 SummaryArdent Health Partners beats Fulgent Genetics on 11 of the 16 factors compared between the two stocks. Remove Ads Get Fulgent Genetics News Delivered to You Automatically Sign up to receive the latest news and ratings for FLGT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FLGT vs. The Competition Export to ExcelMetricFulgent GeneticsMedical laboratories IndustryMedical SectorNASDAQ ExchangeMarket Cap$526.27M$2.83B$5.63B$7.84BDividend YieldN/A22.59%5.33%4.01%P/E Ratio-3.0913.1723.5818.74Price / Sales1.86202.00388.2390.77Price / Cash5.1257.5638.1734.64Price / Book0.454.356.894.23Net Income-$167.82M-$22.21M$3.20B$247.47M7 Day Performance-0.23%51.05%-3.06%-2.29%1 Month Performance10.36%12.95%1.51%-5.81%1 Year Performance-21.43%-3.70%9.37%-0.96% Fulgent Genetics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FLGTFulgent Genetics2.8908 of 5 stars$17.05+1.2%$16.00-6.2%-21.4%$526.27M$283.47M-3.091,010Short Interest ↑Positive NewsHigh Trading VolumeARDTArdent Health PartnersN/A$13.30+1.2%$21.18+59.2%N/A$1.90B$5.97B0.0024,200Analyst ForecastNews CoveragePositive NewsPGNYProgyny2.1166 of 5 stars$22.05+0.9%$24.82+12.6%-42.6%$1.88B$1.17B38.02310Positive NewsAGLagilon health1.0338 of 5 stars$4.47-1.4%$3.95-11.4%-26.5%$1.84B$6.06B-4.75650Positive NewsPACSPACS Group3.8336 of 5 stars$11.91+3.5%$34.00+185.5%N/A$1.82B$3.56B0.0032,433Options VolumeNews CoverageADUSAddus HomeCare4.8607 of 5 stars$90.98+1.3%$132.78+45.9%-5.8%$1.65B$1.15B20.8233,200Positive NewsTDOCTeladoc Health3.1598 of 5 stars$8.86+5.3%$11.26+27.2%-46.3%$1.46B$2.57B-1.535,100NHCNational HealthCareN/A$91.46+0.8%N/AN/A$1.41B$1.30B11.4612,400Positive NewsAHCOAdaptHealth3.5245 of 5 stars$10.39+4.0%$13.80+32.8%-7.6%$1.40B$3.26B-6.3010,900Positive NewsVRDNViridian Therapeutics1.1865 of 5 stars$15.46+1.3%$35.70+130.9%-17.5%$1.26B$302,000.00-3.5950Positive NewsGRALGrail0.7402 of 5 stars$32.13+6.1%$20.00-37.8%N/A$1.09B$125.60M0.001,360Positive NewsGap Up Remove Ads Related Companies and Tools Related Companies ARDT Competitors PGNY Competitors AGL Competitors PACS Competitors ADUS Competitors TDOC Competitors NHC Competitors AHCO Competitors VRDN Competitors GRAL Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FLGT) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredAI Boom Takes a Shocking Turn…A potentially historic moment for retirement Let's make the most of this market together. Crypto 101 Media | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHuge Elon-backed AI rollout begins – buy these nine stocksIf you suspect Elon Musk has an ulterior motive for coming to Washington, D.C.... You're 100% correct. ...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Fulgent Genetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Fulgent Genetics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy FLGT Stock Free FLGT Stock Alerts